Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.

A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80

The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet (1992) 8.20

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA (2006) 5.51

Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A (2010) 3.20

Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06

Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res (2003) 3.02

Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet (1997) 2.28

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer (2009) 2.21

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev (2005) 2.00

Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat (2010) 1.96

Alternative splicing: current perspectives. Bioessays (2008) 1.95

Characterization of common BRCA1 and BRCA2 variants. Genet Test (2002) 1.70

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat (2003) 1.54

An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet (1999) 1.52

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J (2010) 1.52

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat (2010) 1.40

Pathology of hereditary breast cancer. Cell Oncol (Dordr) (2011) 1.28

Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med (2010) 1.26

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res (2008) 1.24

A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res (2005) 1.23

Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet (2005) 1.12

The GenoChip: a new tool for genetic anthropology. Genome Biol Evol (2013) 1.12

Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer (2012) 1.11

The BRCA1 RING and BRCT domains cooperate in targeting BRCA1 to ionizing radiation-induced nuclear foci. J Biol Chem (2004) 1.11

Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet (2004) 1.10

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat (2010) 1.04

Common variants of DNA repair genes and malignant melanoma. Eur J Cancer (2007) 1.02

A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int (2013) 1.02

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat (2002) 0.98

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer (2014) 0.97

Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet (2007) 0.95

Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer (2001) 0.94

Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat (2006) 0.92

Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet (2006) 0.92

Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. Am J Hum Genet (1998) 0.90

Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism. Breast Cancer Res (2007) 0.89

BRCA1 and BRCA2 mutations in Russian familial breast cancer. Hum Mutat (2002) 0.89

A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2. Am J Hum Genet (1998) 0.88

The genetic history of indigenous populations of the Peruvian and Bolivian Altiplano: the legacy of the Uros. PLoS One (2013) 0.87

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review. Int J Surg Oncol (2011) 0.86

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia. Hered Cancer Clin Pract (2014) 0.84

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective. Breast Cancer Res Treat (2015) 0.83

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru. Clin Genet (2014) 0.83

Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes Cancer (2006) 0.83

Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast. Hum Mutat (2011) 0.82

Breast cancer gene variants: separating the harmful from the harmless. J Clin Invest (2009) 0.81

Caucasian family with two independent mutations: 2594delC in BRCA1 and 5392delAG in BRCA2 gene. Am J Med Genet (2001) 0.81

The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts. Breast Cancer Res Treat (2008) 0.80

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC Med Genet (2014) 0.80

Segregation of two BRCA1 mutations in a single family. Am J Hum Genet (1996) 0.79

BRCA1 polymorphism in breast cancer patients from Argentina. Oncol Lett (2014) 0.78

Genomic rearrangements of the BRCA1 gene in Chilean breast cancer families: an MLPA analysis. Breast Cancer Res Treat (2011) 0.77

Co-segregation of BRCA1 185delAG mutation and BRCA2 6174delT in one single family. Eur J Cancer (1997) 0.76

An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2. Clin Genet (2000) 0.76

Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage. Radiat Res (2010) 0.76

cDNA analysis of the BRCA1 unclassified variant c.5194-12G>A. Clin Genet (2012) 0.76